- Filed
- Jan 10, 2025 12:00 AM ET
- Period of report
- —
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Short Term Investments | Q1 2025 · Nov 30, 2024 | $14.73M |
| Short Term Investments | Q1 2025 · Aug 31, 2024 | $13.51M |
| Cash And Equivalents | Q1 2025 · Nov 30, 2024 | $166.25M |
| Cash And Equivalents | Q1 2025 · Aug 31, 2024 | $161.57M |
| Current Liabilities | Q1 2025 · Nov 30, 2024 | $260.9M |
| Current Liabilities | Q1 2025 · Aug 31, 2024 | $281.44M |
| Total Liabilities | Q1 2025 · Nov 30, 2024 | $568.11M |
| Total Liabilities | Q1 2025 · Aug 31, 2024 | $587.9M |
| Current Assets | Q1 2025 · Nov 30, 2024 | $916.4M |
| Current Assets | Q1 2025 · Aug 31, 2024 | $915.68M |
| Total Assets | Q1 2025 · Nov 30, 2024 | $2.7B |
| Total Assets | Q1 2025 · Aug 31, 2024 | $2.7B |
| Shares Diluted | Q1 2025 · Nov 25, 2023 | 18.77M sh |
| Stock Repurchased | Q1 2025 · Nov 25, 2023 | $255K |
| Dividends Paid | Q1 2025 · Nov 25, 2023 | $5.57M |
| Capex | Q1 2025 · Nov 25, 2023 | $39.05M |
| Operating Cash Flow | Q1 2025 · Nov 25, 2023 | $45.67M |
| Stockholders Equity | Q1 2025 · Nov 25, 2023 | $2.04B |
| Stockholders Equity | Q1 2025 · Aug 26, 2023 | $2B |
| Eps Diluted | Q1 2025 · Nov 25, 2023 | $2.26 |
| Sga Expense | Q1 2025 · Nov 25, 2023 | $122.86M |
| Net Income | Q1 2025 · Nov 25, 2023 | $42.33M |
| Operating Income | Q1 2025 · Nov 25, 2023 | $53.14M |
| Cost Of Revenue | Q1 2025 · Nov 25, 2023 | $383.8M |
| Revenue | Q1 2025 · Nov 25, 2023 | $593.53M |